Article info

Download PDFPDF

Original article
Effect of Fcγ-receptor 3a (FCGR3A) gene polymorphisms on rituximab therapy in Hungarian patients with rheumatoid arthritis

Authors

  1. Correspondence to Dr Zoltan Szekanecz; szekanecz.zoltan{at}med.unideb.hu
View Full Text

Citation

Pál I, Szamosi S, Hodosi K, et al
Effect of Fcγ-receptor 3a (FCGR3A) gene polymorphisms on rituximab therapy in Hungarian patients with rheumatoid arthritis

Publication history

  • Received April 24, 2017
  • Revision received October 10, 2017
  • Accepted October 11, 2017
  • First published November 1, 2017.
Online issue publication 
November 01, 2017

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.